CASI Pharmaceuticals
CASI
#8912
Rank
C$0.11 B
Marketcap
$7.51
Share price
-3.96%
Change (1 day)
22.15%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -C$36.41 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are C$23.1 Million. In 2023 the company made an earning of -C$37.16 Million, an increase over its 2022 earnings that were of -C$52.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$36.41 Million-2%
2023 -C$37.16 Million-29.55%
2022 -C$52.74 Million4.43%
2021 -C$50.5 Million-24.56%
2020 -C$66.94 Million4.74%
2019 -C$63.91 Million65.13%
2018 -C$38.71 Million155.07%
2017 -C$15.18 Million13.93%
2016 -C$13.32 Million31.18%
2015 -C$10.16 Million-72.5%
2014 -C$36.92 Million356.62%
2013 -C$8.09 Million-60.55%
2012 -C$20.5 Million218.41%
2011 -C$6.44 Million0.74%
2010 -C$6.39 Million-32.54%
2009 -C$9.47 Million-66.98%
2008 -C$28.68 Million-14.22%
2007 -C$33.44 Million7.04%
2006 -C$31.24 Million27.95%
2005 -C$24.42 Million4.51%
2004 -C$23.36 Million-15.84%
2003 -C$27.76 Million-55.29%
2002 -C$62.08 Million-34.05%
2001 -C$94.13 Million31.73%
2000 -C$71.46 Million31.56%
1999 -C$54.32 Million145.56%
1998 -C$22.12 Million76.4%
1997 -C$12.54 Million36.92%
1996 -C$9.16 Million